Psychedelics Can Reverse Brain-Immune Interactions That Elevate Fear, Study Finds
Recent research from Mass General Brigham has shed new light on how immune and neural interactions contribute to fear and stress responses. The study reveals that immune cells and brain cells communicate in ways previously unrecognized, influencing behaviors related to fear. Researchers found that treatments with psychedelics such as MDMA and psilocybin can modulate these neuroimmune interactions, potentially reducing fear and inflammation.
The findings demonstrate that immune signaling can affect stress-related behavior by altering communication within the brain, particularly in the amygdala, the region responsible for processing fear. In animal models subjected to chronic stress, enhanced interaction between immune and brain cells heightened fear responses, increased inflammatory signals, and activated neurons that promote fear. Notably, immune cells called monocytes migrated into brain structures during stress, and manipulating these cells affected fear behaviors.
Importantly, psychedelic treatments prevented monocyte infiltration and lowered fear in stressed animals. These effects were also observed in human tissue samples and gene expression data from patients with major depressive disorder (MDD), suggesting similar neuroimmune mechanisms could be involved in human neuropsychiatric conditions.
Lead researcher Dr. Michael Wheeler emphasized that psychedelics may extend beyond altering perception to helping reset inflammation and brain-immune communication. The research opens avenues for new treatments targeting immune system involvement in anxiety, depression, and inflammatory diseases.
Future work aims to explore the long-term effects of psychedelic therapy on patients with depression and inflammatory disorders. Dr. Wheeler noted ongoing collaborations on clinical trials involving psychedelic treatments, emphasizing the potential for these substances to offer tissue-specific benefits. However, he clarified that psychedelics are not a universal cure but present promising possibilities for therapeutic development.
This groundbreaking study highlights how enhancing our understanding of neuroimmune interactions could revolutionize approaches to mental health and inflammatory conditions.
(Source: https://medicalxpress.com/news/2025-04-psychedelics-reverse-neuroimmune-interactions-boost.html)
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Link Between Mitochondrial Nucleotide Balance and Age-Related Inflammation
New research links the imbalance of mitochondrial nucleotides to age-related inflammation, shedding light on mechanisms driving aging and disease progression. Discover how mitochondrial DNA integrity affects immune activation and potential therapeutic approaches.
Understanding How Cancer Misinformation Exploits Human Psychology
Cancer misinformation spreads rapidly on social media by exploiting emotions and psychological biases, risking delays in treatment and trust in healthcare. Learn how to recognize and resist false claims to make better health decisions.
Breakthrough Phase III Clinical Trial Demonstrates Effectiveness of Gene-Engineered Skin Grafts in Healing Chronic Blistering Wounds in Dystrophic Epidermolysis Bullosa
A groundbreaking Phase III trial reveals that gene-engineered skin grafts significantly improve healing and quality of life for patients with severe dystrophic epidermolysis bullosa, a rare genetic skin disorder.
Breakthrough Study Uncovers Early Indicators of Ovarian Cancer Risk
Researchers at Mayo Clinic have identified early cellular changes in the fallopian tubes that may signal the risk of developing ovarian cancer, paving the way for improved early detection and prevention methods.